文献速递疼痛医学区域麻醉与超声神经外科与老年麻醉

截肢相关神经病理性疼痛的治疗方法:手术、介入与药物治疗的叙述性综述

Approaches to neuropathic amputation-related pain: narrative review of surgical, interventional, and medical treatments.
PubMed 文献 · Reg Anesth Pain Med · 2024-12-02

截肢相关神经病理性疼痛包括幻肢痛(PLP)、残肢痛(RLP)或两者并存,终生患病率估计在8%至72%之间。本叙述性综述评估了手术与非手术治疗选项,发现多数干预证据不确定且缺乏高确定性,靶向肌肉神经再支配和区域周围神经接口是减少神经瘤和PLP的主要手术选择,多模式联合药物、手术和侵入性神经调控似乎是最有前景的策略。

要点

  • 靶向肌肉神经再支配和区域周围神经接口是减少神经瘤和幻肢痛的主要手术选择。
  • 脊髓、背根神经节和/或周围神经的神经调控可作为幻肢痛的辅助治疗。
  • 多模式联合药物、手术和侵入性神经调控是预防和治疗截肢后疼痛最有前景的策略。

核心结论

  • 多模式联合药物、手术和侵入性神经调控似乎是预防和治疗幻肢痛和残肢痛最有前景的策略。
  • 未来应聚焦跨学科教育以提高对治疗选项的认识,探索截肢时预防疼痛的最佳实践并改善慢性截肢后疼痛的治疗。

研究设计与样本

  • 叙述性综述,检索英文文献,关键词包括PLP、amputation pain、RLP,评估摘要和全文中的手术治疗、药物管理、区域麻醉、周围阻滞、神经调控、脊髓刺激、背根神经节和周围神经刺激。

主要发现

  • 支持大多数(若非全部)幻肢痛干预措施的证据不确定且缺乏高确定性。
  • 靶向肌肉神经再支配和区域周围神经接口是减少神经瘤形成和减少幻肢痛的主要手术治疗选项。
  • 非手术选项包括药物治疗、区域介入技术和行为疗法,可使某些患者获益。
  • 越来越多的证据表明脊髓或背根神经节和/或周围神经的神经调控可作为幻肢痛的辅助治疗。

关键数值与推荐

  • 截肢后疼痛的终生患病率估计范围在8%至72%之间。

临床怎么用

  • 临床应采用多学科协作制定多模式治疗方案,结合药物、手术和介入神经调控。
  • 手术选项可考虑靶向肌肉神经再支配和区域周围神经接口以减少神经瘤和幻肢痛。
  • 非手术选项包括药物治疗、区域介入技术和行为疗法,可选择性用于某些患者。
  • 神经调控(脊髓、背根神经节和/或周围神经)可作为幻肢痛的辅助治疗。

局限性

  • 支持大多数幻肢痛干预措施的证据不确定且缺乏高确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/IMPORTANCE: Neuropathic amputation-related pain can consist of phantom limb pain (PLP), residual limb pain (RLP), or a combination of both pathologies. Estimated of lifetime prevalence of pain and after amputation ranges between 8% and 72%. OBJECTIVE: This narrative review aims to summarize the surgical and non-surgical treatment options for amputation-related neuropathic pain to aid in developing optimized multidisciplinary and multimodal treatment plans that leverage multidisciplinary care. EVIDENCE REVIEW: A search of the English literature using the following keywords was performed: PLP, amputation pain, RLP. Abstract and full-text articles were evaluated for surgical treatments, medical management, regional anesthesia, peripheral block, neuromodulation, spinal cord stimulation, dorsal root ganglia, and peripheral nerve stimulation. FINDINGS: The evidence supporting most if not all interventions for PLP are inconclusive and lack high certainty. Targeted muscle reinnervation and regional peripheral nerve interface are the leading surgical treatment options for reducing neuroma formation and reducing PLP. Non-surgical options include pharmaceutical therapy, regional interventional techniques and behavioral therapies that can benefit certain patients. There is a growing evidence that neuromodulation at the spinal cord or the dorsal root ganglia and/or peripheral nerves can be an adjuvant therapy for PLP. CONCLUSIONS: Multimodal approaches combining pharmacotherapy, surgery and invasive neuromodulation procedures would appear to be the most promising strategy for preventive and treating PLP and RLP. Future efforts should focus on cross-disciplinary education to increase awareness of treatment options exploring best practices for preventing pain at the time of amputation and enhancing treatment of chronic postamputation pain.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Markewych AN, Suvar T, Swanson MA, et al. Approaches to neuropathic amputation-related pain: narrative review of surgical, interventional, and medical treatments. Reg Anesth Pain Med. 2024. PMID: 38307612. doi:10.1136/rapm-2023-105089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。